MedTrace Logo

Responses to Information on Treatments for Depression

NCT04639765 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2021-09-05

No results posted yet for this study

Summary

The purpose of this study is to determine the impact of different messages about depression treatments.

Conditions

  • Depressive Symptoms

Interventions

OTHER

CBT without Personalization

Intervention involves a video describing CBT without a message about personalization.

OTHER

CBT with Personalization

Intervention involves a video describing CBT with a message about personalization.

OTHER

ADM without Personalization

Intervention involves a video describing antidepressant medication without a message about personalization.

OTHER

ADM with Personalization

Intervention involves a video describing antidepressant medication with a message about personalization.

OTHER

Combined Treatment without Personalization

Intervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication without a message about personalization.

OTHER

Combined Treatment with Personalization

Intervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication with a message about personalization.

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Daniel Strunk, PhD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-28
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04639765 on ClinicalTrials.gov